Seung-Ki Kwok is a Professor of Division of Rheumatology at Seoul St. Mary's Hospital in the Catholic University of Korea. He received his M.D. and Ph.D. at the College of Medicine, the Catholic University of Korea. He was a research fellow in the Division of Rheumatology at Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School. His major research interest is to elucidate the pathogenic mechanism of autoimmune diseases and thereby to develop therapies to treat autoimmune and rheumatic diseases, with a focus on systemic lupus erythematosus (SLE), Sjogren’s syndrome, rheumatoid arthritis (RA) and systemic sclerosis. For the last several years, he has done diverse translational research of autoimmune diseases using animal models and patient samples in an attempt to find out new treatment targets. He has published numerous articles in the field autoimmune research such as Nature Review Rheumatology, the Journal of Immunology, and Arthritis & Rheumatology. He is also interested in cell therapy using mesenchymal stromal cells (MSCs), myeloid-derived suppressor cells (MDSCs) and adipose tissue derived stromal vascular fraction (SVF) to treat intractable autoimmune diseases.
Research & Clinical Focus
To elucidate the pathogenic mechanisms of autoimmune diseases including SLE, Sjogren’s syndrome, RA, systemic sclerosis
Cell therapy using MDSCs(Myeloid-derived suppressor cells), MSCs(Mesenchymal stromal cells) and adipose tissue derived stromal vascular fraction (SVF)
Clinical and translational research of Sjogren’s syndrome and SLE